fingolimod hydrochloride has been researched along with tamoxifen in 2 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Georgakopoulos, CD; Georgalas, I; Makri, OE | 1 |
Alvarez, RD; Arend, RC; Fehling, SC; Gamblin, TL; Katre, AA; Kreitzburg, KM; Landen, CN; Oliver, PG; van Waardenburg, RCAM; Vance, RB; Yoon, KJ | 1 |
1 review(s) available for fingolimod hydrochloride and tamoxifen
Article | Year |
---|---|
Drug-induced macular edema.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Fingolimod Hydrochloride; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Interferons; Macular Edema; Niacin; Ophthalmic Solutions; Propylene Glycols; Sphingosine; Tamoxifen; Taxoids; Thiazolidinediones; Timolol | 2013 |
1 other study(ies) available for fingolimod hydrochloride and tamoxifen
Article | Year |
---|---|
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Fingolimod Hydrochloride; Humans; Mice; Ovarian Neoplasms; Tamoxifen; Xenograft Model Antitumor Assays | 2018 |